United States · Biotechnology startup
United States · Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
Funding reportedLast round: Post ipo equity
What company datasets say Nautilus Biotechnology raised
Funding, as reported
Reported in all$303Min dollars
Rounds3
Last roundPost ipo equity
Last round dateJun 2021
Investors listed15
Founders and team
From Nautilus Biotechnology's own website and the SEC filings it signed: 1 founder, 7 on the team.
- Gwen WeldChief People Officer
- Anna MowryChief Financial Officer
- Amber FaustVP, Global Sales
- Matthew S. MurphyExecutive Officeri
- Nicholas S. NelsonExecutive Officeri
- Parag MallickExecutive Officer, Directori
- Subra S. SankarExecutive Officeri
On the board, as filediFarzad NazemMatthew PosardMatthew S. McIlwainMelissa EpperlyMichael AltmanVijay Pande
On a portfolio page
Investors who name them
Each firm lists Nautilus Biotechnology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Nautilus Biotechnology in front of investors. Or tell us what we have wrong.